Real-World Study Tracks Discontinuation and Optimization in Parkinson’s Device Therapies
A prospective multicenter registry study revealed that nearly one-third of infusion therapies for Parkinson's disease were discontinued, while deep brain ...
A prospective multicenter registry study revealed that nearly one-third of infusion therapies for Parkinson's disease were discontinued, while deep brain ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.